PAR 5.88% 24.0¢ paradigm biopharmaceuticals limited..

Ann: EMA PROVIDES KEY PATH TOWARD PHASE 3 TRIALS AND REGISTRATION, page-30

  1. 594 Posts.
    lightbulb Created with Sketch. 135
    I have never seen him put a price target on PAR.

    He has called APT and A2 very well. Like everyone, he has had some doozies, but for the most part he is worth listening to.

    Outstanding news on Bene. Will be interesting to see if the market understands the importance of this message. Like the fact that it is also from marketing approval and not a set date. Patent expiry dates get closer with delays while agreement with Bene trigger once approved as I understand it. Smart move.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
-0.015(5.88%)
Mkt cap ! $84.05M
Open High Low Value Volume
25.5¢ 26.5¢ 24.0¢ $167.2K 671.5K

Buyers (Bids)

No. Vol. Price($)
3 108741 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
25.5¢ 9700 2
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.